Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06713031

Medial Enhancement Technique for the Treatment of Old Femoral Neck Fractures

A prospective, multi-center, randomized controlled study was conducted to validate the safety and effectiveness of employing the medial augmentation technique (incorporating the dynamic condylar screw and medial support plate) supplemented with bone grafting for the treatment of old femoral neck fractures.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Chinese PLA General Hosptial

Beijing, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age >= 18 years, gender not specified;
  • Patients with femoral neck fractures who have not undergone surgery for more than 3 weeks, or patients with persistent non-union following internal fixation of femoral neck fractures;
  • Have indications for internal fixation surgery for femoral neck fractures and are able to tolerate the surgery;
  • Participants or their legal representatives are informed about the nature of this study and agree to participate.

Exclusion criteria

  • Participants who have not reached the primary endpoint of other drug, biological agent, or medical device clinical trials prior to enrollment;
  • Known history of hypersensitivity to one or more implanted materials by the patient;
  • Judged by the investigator as physically frail or unable to tolerate surgery due to other systemic diseases;
  • Active infectious foci in the hip joint or other parts of the body, as judged by the investigator;
  • Diagnosed with metabolic bone disease, radiation-induced bone disease, etc.;
  • Severe hip contracture deformity or severe muscle weakness that has been immobilized in functional position for a long time and painless;
  • Suffering from inflammatory arthritis, such as rheumatoid arthritis, systemic lupus erythematosus arthritis, ankylosing spondylitis, etc.;
  • Patients who lack the mental capacity or understanding to meet the requirements of participating in the study, or are difficult to cooperate with;
  • Other situations where the investigator deems the participant unsuitable for inclusion.

Treatment and study plan

cannulated compression screws + iliac bone graft

Procedure

Using "cannulated compression screws + iliac bone graft" technique to treat old femoral neck fractures

DCS + medial support plate + iliac bone graft

Procedure

Using "DCS + medial support plate + iliac bone graft" technique to treat old femoral neck fractures

Primary outcomes

  1. Fracture healing rate

    Time frame: 1 year

Secondary outcomes

  1. Femoral head necrosis

    Time frame: 1 year

    Commonly used imaging tools include X-rays, Magnetic Resonance Imaging (MRI), and Computerized Tomography (CT). X-rays are the most commonly employed assessment tool, capable of displaying the morphology of the femoral head and whether the bone structure is normal. MRI and CT can provide more detailed images, aiding in the determination of the extent and range of femoral head necrosis.

  2. Harris score

    Time frame: 1 year

    The Harris Score (Harris Hip Score, HHS) is a widely used scale for evaluating hip joint function and patient quality of life, often applied to assess the outcomes of hip replacement surgery or other treatments for hip joint diseases. It covers four main aspects: pain level, functional activity, joint range of motion, and hip joint deformity. The total score ranges from 0 to 100, with 100 being the best possible condition, indicating complete normalcy of hip joint function.

  3. VAS score

    Time frame: 1 year

    The VAS score (Visual Analog Scale) is a commonly used tool for quantifying pain assessment that is suitable for measuring various degrees of pain. The VAS score typically employs a straight line 10 centimeters long (or an equivalent visual scale), with each end marked as "No Pain" and "Most Intense Pain" respectively. A straight line 10 centimeters long (or an equivalent visual scale) is often utilized, with each end labeled as "No Pain" and "Most Intense Pain."

  4. Complications

    Time frame: 1 year

    Focusing on perioperative complications in patients, indications and symptoms of incision infection, including redness, swelling, drainage, and fever, should be carefully monitored. The incidence and severity of infection cases should be recorded and analyzed to evaluate the risk factors for postoperative infection and the effectiveness of preventive strategies. Unplanned reoperations should be recorded, including cases of primary surgery failure, development of complications, or other situations necessitating further surgical intervention. Detailed records of the causes, timing, and outcomes of reoperations will help evaluate the reliability of surgical techniques and internal fixation devices. Additionally, other postoperative complications, such as femoral head necrosis, repositioning of fracture ends, fixation loosening and breakage, should be meticulously recorded and observed.

Study contacts

Contact information is provided by the study sponsor or research team.

Wei Zhang

CONTACT

[email protected]

+8612409252

Sponsors and collaborators

Lead sponsor

Chinese PLA General Hospital

Other

Registry information

Official study title

Prospective, Multicenter, Randomized Controlled Clinical Study of Medial Enhancement Technique for the Treatment of Old Femoral Neck Fractures

Important dates

Study start
2024
Primary completion
2024
Study completion
2026
First posted
Dec 3, 2024
Registry last updated
Dec 4, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.